Potential Medicare Part D Savings on Ophthalmic Generic Drugs

被引：3
|
作者：
Collet, David A. [1 ]
Urban, Matthew B. [1 ]
Amin, Abha [2 ]
机构：
[1] New York Med Coll, Sch Med, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Dept Ophthalmol, Valhalla, NY USA
来源：
JAMA OPHTHALMOLOGY | 2024年 / 142卷 / 07期
关键词：
D O I：
10.1001/jamaophthalmol.2024.1717
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
This economic evaluation assesses potential Medicare Part D savings on ophthalmic generic drugs if discount coupon prices are used.
引用
收藏
页码：678 / 680
页数：3
相关论文
共 50 条
  • [1] Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label
    Egilman, Alexander C.
    Kesselheim, Aaron S.
    Sarpatwari, Ameet
    Rome, Benjamin N.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : 833 - 835
  • [2] Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company
    Lalani, Hussain S.
    Kesselheim, Aaron S.
    Rome, Benjamin N.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (07) : 1053 - 1055
  • [3] Overpayment for Generic Drugs Under Medicare Part D
    Hernandez, Inmaculada
    Gabriel, Nico
    Pathak, Yuvraj
    Hansen, Ryan N.
    Sullivan, Sean D.
    JAMA HEALTH FORUM, 2025, 6 (02):
  • [4] Geographic Variation in Medicare Part D Spending on Ophthalmic Drugs
    Liles, Nathan William Anderson
    Woodward, Maria A.
    Newman-Casey, Paula Anne
    Delott, Lindsay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Reimbursement to Pharmacies for Generic Drugs by Medicare Part D Sponsors
    Hernandez, Inmaculada
    Gabriel, Nico
    Kaltenboeck, Anna
    Boccuti, Cristina
    Hansen, Ryan N.
    Sullivan, Sean D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (24): : 2390 - 2392
  • [6] Potential Cost Savings in Medicare Part D for Otolaryngologic Medications
    Om B. Tripathi
    Aman M. Patel
    Hassaam S. Choudhry
    David W. Wassef
    Paul T. Cowan
    Richard Chan Woo Park
    Andrey Filimonov
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2025, 77 (4) : 1969 - 1980
  • [7] Potential Savings in Medicare Part D for Common Urological Conditions
    Kirk, Peter S.
    Borza, Tudor
    Dupree, James M.
    Wei, John T.
    Ellimoottil, Chad
    Caram, Megan E. V.
    Burkhardt, Mary
    Heidelbaugh, Joel J.
    Hollenbeck, Brent K.
    Skolarus, Ted A.
    UROLOGY PRACTICE, 2018, 5 (05) : 351 - 358
  • [8] Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company (vol 175, pg 1053, 2022)
    Lalani
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (09) : 1342 - 1342
  • [9] Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program
    Ma, Iris
    Tisdale, Rebecca L.
    Vail, Daniel
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (12): : 1215 - 1223
  • [10] Medicare Part D payments for brand and generic drugs prescribed by dermatologists
    Powell, Helen B.
    Adamson, Adewole S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : 575 - 577
12345